Thermo Fisher Scientific stock is trading -21.47% below its average target price of $653.35 after dropping -3.7% during today's afternoon session. Analysts are giving the Large-Cap Farm & Heavy Construction Machinery company an average rating of buy and target prices ranging from $585.2 to $767.0 per share.
The stock has a very low short interest at 0.8%, and a short ratio of 2.26. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 90.9% of Thermo Fisher Scientific's shares being owned by this investor type.
Institutions Invested in Thermo Fisher Scientific
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 33,052,711 | $16,958,685,524 |
| 2024-09-30 | Blackrock Inc. | 8% | 29,157,047 | $14,959,898,173 |
| 2024-09-30 | State Street Corporation | 4% | 16,318,961 | $8,372,932,788 |
| 2024-06-30 | Morgan Stanley | 3% | 12,097,513 | $6,206,992,176 |
| 2024-09-30 | Price (T.Rowe) Associates Inc | 3% | 10,973,057 | $5,630,056,273 |
| 2024-09-30 | Capital World Investors | 2% | 9,325,777 | $4,784,869,822 |
| 2024-09-30 | Capital Research Global Investors | 2% | 8,187,683 | $4,200,936,533 |
| 2024-09-30 | FMR, LLC | 2% | 7,877,459 | $4,041,766,798 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 7,659,943 | $3,930,163,685 |
| 2024-09-30 | JP Morgan Chase & Company | 2% | 6,606,909 | $3,389,872,982 |
Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Thermo Fisher Scientific.
